Home > Insider Trading > Filing (0001209191-21-009470)

Filing Details

Accession Number:: 0001209191-21-009470
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-10 20:29:26
Reporting Period:: 2021-02-08

Accepted Time:: 2021-02-10 20:29:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180262	Herbalife Nutrition Ltd.	HLF	Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1311282	David Pezzullo	800 W. Olympic Blvd Suite 406 Los Angeles CA 90015	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-08	20,764	$26.65	168,737	No	4	M	Direct
Common Stock	Disposition	2021-02-08	13,743	$55.83	154,994	No	4	F	Direct
Common Stock	Acquisiton	2021-02-08	6,816	$33.85	161,810	No	4	M	Direct
Common Stock	Disposition	2021-02-08	5,061	$55.83	156,749	No	4	F	Direct
Common Stock	Acquisiton	2021-02-08	29,508	$39.79	186,257	No	4	M	Direct
Common Stock	Disposition	2021-02-08	24,579	$55.83	161,678	No	4	F	Direct
Common Stock	Acquisiton	2021-02-08	43,668	$31.26	205,346	No	4	M	Direct
Common Stock	Disposition	2021-02-08	33,978	$55.83	171,368	No	4	F	Direct
Common Stock	Acquisiton	2021-02-08	45,902	$28.60	217,270	No	4	M	Direct
Common Stock	Disposition	2021-02-08	34,614	$55.83	182,656	No	4	F	Direct
Common Stock	Acquisiton	2021-02-08	35,642	$0.00	218,298	No	4	A	Direct
Common Stock	Disposition	2021-02-08	17,672	$55.83	200,626	No	4	F	Direct
Common Stock	Disposition	2021-02-10	5,644	$56.73	194,982	No	4	S	Direct
Common Stock	Disposition	2021-02-10	15,801	$57.61	179,181	No	4	S	Direct
Common Stock	Disposition	2021-02-10	13,238	$58.35	165,943	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2021-02-08	20,764	$0.00	20,764	$26.65
Common Stock	Stock Appreciation Rights	Disposition	2021-02-08	6,816	$0.00	6,816	$33.85
Common Stock	Stock Appreciation Rights	Disposition	2021-02-08	29,508	$0.00	29,508	$39.79
Common Stock	Stock Appreciation Rights	Disposition	2021-02-08	43,668	$0.00	43,668	$31.26
Common Stock	Stock Appreciation Rights	Disposition	2021-02-08	45,902	$0.00	45,902	$28.60

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2014-05-18	2021-05-18	No	4	M	Direct
2015-03-01	2022-03-01	No	4	M	Direct
2016-06-21	2023-12-19	No	4	M	Direct
2019-05-09	2026-05-09	No	4	M	Direct
2020-02-27	2027-02-27	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period.
Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs.
This transaction was executed in multiple trades at prices ranging from $56.2100 to $56.9900. The price reported reflects the weighted average sale price of $56.7262. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $57.0900 to $57.9900. The price reported reflects the weighted average sale price of $57.6139. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $58.0000 to $58.6250. The price reported reflects the weighted average sale price of $58.3540. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering10,382 shares at an exercise price of $53.29 per share.
The SARS were granted on May 18, 2011. 20% vested on May 18, 2012, 20% vested on May 18, 2013 and the remaining 60% vested on May 18, 2014.
Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 3,408 shares at an exercise price of $67.70 per share.
The SARS were granted on March 1, 2012. 20% vested on March 1, 2013, 20% vested on March 1, 2014 and the remaining 60% vested on March 1, 2015.
Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 14,754 shares at an exercise price of $79.58 per share.
The SARS were granted on December 19, 2013. 20% vested on June 21, 2014, 20% vested on June 21, 2015 and the remaining 60% vested on June 21, 2016.
Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 21,834 shares at an exercise price of $62.51 per share.
The SARS were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019.
Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 22,951 shares at an exercise price of $57.19 per share.
The SARS were granted on February 27, 2017. 20% vested on February 27, 2018, 20% vested on February 27, 2019 and the remaining 60% vested on February 27, 2020.